Julia G. Butchko

CIK 1796290 · Chief Development Officer · last filed 2024-08-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$14.83M

Companies

2

Total Filings

32

Lifetime Open-Market Net

-$2.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMVT Chief Development Officer 441,079 $33.62 $14.83M -$2.53M 30 2024-08-23
Immunovant, Inc. (IMVTW) Delisted Chief Dev. & Tech. Officer $0 2 2020-05-18

Recent Filings · Page 2 of 4

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-10-06 IMVT Sell (S) −1,735 -$62.9K EDGAR
2023-08-25 IMVT Sell (S) −12,333 -$250.4K EDGAR
2023-07-13 IMVT Sell (S) −1,470 -$29.0K EDGAR
2023-04-19 IMVT Sell (S) −1,544 -$23.6K EDGAR
2023-04-14 IMVT Grant (A) +100,188 $0 EDGAR
2023-01-13 IMVT Sell (S) −60,490 -$1.02M EDGAR
2022-10-17 IMVT Sell (S) −928 -$8.5K EDGAR
2022-09-29 IMVT Sell (S) −535 -$2.5K EDGAR
2022-09-01 IMVT Sell (S) −548 -$3.2K EDGAR
2022-08-19 IMVT Grant (A) +112,816 $0 EDGAR
Showing 1120 of 32
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.